BRPI0509033A - ferramenta diagnóstica - Google Patents

ferramenta diagnóstica

Info

Publication number
BRPI0509033A
BRPI0509033A BRPI0509033-4A BRPI0509033A BRPI0509033A BR PI0509033 A BRPI0509033 A BR PI0509033A BR PI0509033 A BRPI0509033 A BR PI0509033A BR PI0509033 A BRPI0509033 A BR PI0509033A
Authority
BR
Brazil
Prior art keywords
diagnostic tool
biomarker
sample
individual
various methods
Prior art date
Application number
BRPI0509033-4A
Other languages
English (en)
Inventor
Jose M Carballido Herrera
Claudia Guenther
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0509033A publication Critical patent/BRPI0509033A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

FERRAMENTA DIAGNóSTICA. A presente invenção refere-se a uma ferramenta diagnóstica, como por exemplo, a quimiocina CCL18, como um biomarcador, em uma amostra em um fluido corporal deum indivíduo, e seu uso em vários métodos.
BRPI0509033-4A 2004-03-22 2005-03-21 ferramenta diagnóstica BRPI0509033A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55511004P 2004-03-22 2004-03-22
PCT/EP2005/002986 WO2005093428A2 (en) 2004-03-22 2005-03-21 Chemokine ccl18 as a biomarker

Publications (1)

Publication Number Publication Date
BRPI0509033A true BRPI0509033A (pt) 2007-08-07

Family

ID=34962763

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509033-4A BRPI0509033A (pt) 2004-03-22 2005-03-21 ferramenta diagnóstica

Country Status (10)

Country Link
US (1) US20080305494A1 (pt)
EP (1) EP1738175A2 (pt)
JP (1) JP2007529759A (pt)
CN (1) CN1930476A (pt)
AU (1) AU2005225708A1 (pt)
BR (1) BRPI0509033A (pt)
CA (1) CA2558124A1 (pt)
MX (1) MXPA06010808A (pt)
RU (1) RU2006137326A (pt)
WO (1) WO2005093428A2 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4657697A (en) * 1996-09-30 1998-04-24 Human Genome Sciences, Inc. Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4)
US20020076404A1 (en) * 1998-01-29 2002-06-20 Chang Tse Wen Treating atopic dermatitis with IgE antagonists
US6495128B1 (en) * 1998-11-10 2002-12-17 Human Genome Sciences, Inc. Human chemokine β-7 deletion and substitution proteins
US6838429B2 (en) * 1999-10-22 2005-01-04 Paslin David A Atopic dermatitis treatment method
MXPA03004913A (es) * 2000-12-01 2003-09-05 Schering Corp Usos de genes de mamifero y reactivos relacionados.
AU2003246102A1 (en) * 2002-06-27 2004-01-19 Genox Research, Inc. Method of examining allergic disease and drug for treating the same

Also Published As

Publication number Publication date
CN1930476A (zh) 2007-03-14
WO2005093428A2 (en) 2005-10-06
EP1738175A2 (en) 2007-01-03
US20080305494A1 (en) 2008-12-11
RU2006137326A (ru) 2008-04-27
MXPA06010808A (es) 2006-12-15
JP2007529759A (ja) 2007-10-25
WO2005093428A3 (en) 2006-01-05
AU2005225708A1 (en) 2005-10-06
CA2558124A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
BRPI0515758A (pt) dispositivo de ensaio de diagnóstico
DE502005003150D1 (de) Winkelstabile vorrichtung zur gegenseitigen fixierochenfixationselement
ATE509570T1 (de) Analytisches hilfsmittel mit lanzette und testelement
ATE493932T1 (de) Analytisches hilfsmittel
EP2061907A4 (en) Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
MX2010007680A (es) Sistema para detectar un analito en un fluido corporal.
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
IL182403A0 (en) Systems and methods for ex-vivo organ care
EP2163217A3 (en) Surgical port assembly
MX2007004342A (es) Moleculas cop1 y uso de las mismas.
GT201000037A (es) Depsipéptidos cíclicos
TW200723488A (en) Diagnostic circuit and method therefor
BR112014032274A2 (pt) tira de teste analítico com câmaras receptoras de amostra capilar separadas por uma barreira física de isolamento
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
ITUD20040170A1 (it) Dispositivo integrato per analisi diagnostiche, e relativo procedimento
EP2081029A3 (en) Bio-markers for diagnosing diabetic retinopathy
DE602005015559D1 (de) Pharmakodynamische tests mit durchflusszytometrie
TW200617174A (en) Method of diagnosing lawsonia intracellularis
AU304505S (en) Lancet device
ATE388149T1 (de) Neue azaindol-thiazolinone als krebsmittel
BRPI0509033A (pt) ferramenta diagnóstica
AP2316A (en) Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same.
DE502005002888D1 (de) Ventil für medizinische Instrumente
NO20084599L (no) Sammensetninger, fremgangsmater og kit ved anvendelse av adenosin og inosin i kombinasjon for diagnose og behandling
ATE449332T1 (de) Alterungsbiomarker

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]